Dr. Bibiana da Rocha

Dr. Bibiana da Rocha, MBA, is a seasoned pharmaceutical executive with extensive experience across various roles, currently serving as the General Manager for Iberia at Rhythm Pharmaceuticals Inc. since May 2025. Previous positions include Country Launch Lead for Iberia at argenx, where Dr. da Rocha led the successful launch of Vyvgart and established a new subsidiary, and Medical Director EMEA at PTC Therapeutics, Inc., providing strategic oversight across Southern Europe. Additional roles span medical advisory functions at Shionogi Europe, leadership in rare diseases at Prothena Corporation, project management at Lonza and Grifols, and a postdoctoral fellowship focused on regenerative medicine at PRBB. Dr. da Rocha holds an MBA and multiple advanced degrees, including a PhD in Neuroscience from Harvard Medical School.